Beyond MRSA: The growing menace of hVISA and VISA

被引：3

作者：

Bulchandani, Deepti ^{[1
]}

Nachnani, Jagdish

Fitzsimmons, Curtis

Jost, Paul

Brewer, Joseph

机构：

[1] Univ Missouri, Dept Internal Med, Kansas City, MO 64110 USA

来源：

SOUTHERN MEDICAL JOURNAL | 2008年 / 101卷 / 06期

关键词：

D O I：

10.1097/SMJ.0b013e318172f61f

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：663 / 664

页数：2

共 4 条

[1] Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus [J].

Charles, PGP ;

Ward, PB ;

Johnson, PDR ;

Howden, BP ;

Grayson, ML .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :448-451

[2] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].

Hiramatsu, K ;

Hanaki, H ;

Ino, T ;

Yabuta, K ;

Oguri, T ;

Tenover, FC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136

[3] Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia [J].

Khosrovaneh, A ;

Riederer, K ;

Saeed, S ;

Tabriz, MS ;

Shah, AR ;

Hanna, MM ;

Sharma, M ;

Johnson, LB ;

Fakih, MG ;

Khatib, R .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) :1328-1330

[4] Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus [J].

Tenover, FC ;

Biddle, JW ;

Lancaster, MV .

EMERGING INFECTIOUS DISEASES, 2001, 7 (02) :327-332

← 1 →